S. 27 (112th): Preserve Access to Affordable Generics Act

Introduced:

Jan 25, 2011
112th Congress, 2011–2013

Status:
Died in a previous Congress

This bill was introduced on July 21, 2011, in a previous session of Congress, but was not enacted.

Sponsor:

Herbert “Herb” Kohl
Senator from Wisconsin
Democrat

Text:

Read Text »
Last Updated: Jul 22, 2011
Length: 18 pages

About the bill

Full Title

A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.

Read CRS Summary >

Related Bills

Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.

S. 369 (111th) was a previous version of this bill.

Reported by Committee
Last Action: Oct 15, 2009

What is a bill?

The “S.” in “S. 27” means this is a Senate bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

The bill’s title was written by its sponsor.

History

Introduced
Jan 25, 2011
Reported by Committee
Jul 21, 2011

Details

Cosponsors
9 cosponsors (6D, 2R, 1I) (show)
Committee Assignments

The committee chair determines whether a bill will move past the committee stage.

Votes

There have been no votes related to this bill.

Links & tools

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.

Citation

Click a format for a citation suggestion: